Earlier today, the US Preventive Services Task Force (USPSTF) issued the final version of its revised guidance on screening for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: recommendation, screening, USPSTF | 6 Comments »
As many readers will be aware, the U.S. Preventive Services Task Force (USPSTF) recently issued new, draft guidance on the role of testing for risk of prostate cancer, and most particularly on the use of PSA testing in men of 55 years and older. All public comment on the proposed new draft recommendations is due on or before May 8 upcoming. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guidance, recommendation, screening, testing, USPSTF | 8 Comments »
The American Urological Association (AUA), along with other organizations, issued a statement yesterday regarding their reactions to the new, draft guidance issues by the U.S. Preventive Services Task Force (USPSTF). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: risk, screening, testing, USPSTF | 2 Comments »
As indicated earlier this morning, the US Preventive Services Task Force (USPSTF) has issued new draft guidance on screening for risk of prostate cancer. Access to all the relevant details is provided below: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guidance, PSA, screening, testing, USPSTF | 17 Comments »
As yet we have not seen the details, but, according to a report on National Public Radio early this morning, the US Preventive Services Task Force (USPSTF) has stated that men up to age 70 should discuss the risk and benefits of PSA testing with their doctors and then make individual decisions about whether to get tested. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, testing, USPSTF | 4 Comments »
As many readers will be aware, the U.S. Preventive Services Task Force (USPSTF) is in process of developing a new “evidence report” which will form the basis of any update to current USPSTF recommendations about prostate cancer screening. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, USPSTF | 3 Comments »
Another new article (this time in the journal JAMA Surgery) has tried to draw links between the USPSTF guidance on prostate cancer screening and a decrease in the numbers of men being referred to urologists for prostate biopsies and radical prostatectomies. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, PSA, risk, surgery, test, USPSTF | 1 Comment »
A commentary in this week’s issue of the New England Journal of Medicine provides some valuable, historical insight into how it was that the U.S. Preventive Services Task Force (USPSTF) ended up with responsibilities that many of its members never wanted. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: PSA, recommendation, risk, screening, testing, USPSTF | 1 Comment »
In an important editorial, just published in the Annals of Internal Medicine, three former senior members of the U.S. Preventive Services Task Force (USPSTF) argue that it may be time for de-linkage of the recommendations of the Task Force from decisions about whether specific types of preventive care should be covered under the Affordable Care Act. … READ MORE …
Filed under: Uncategorized | Tagged: USPSTF | 2 Comments »
We don’t often refer to articles in what are primarily political publications like The Hill, but an OpEd in that journal this week did catch our attention, and not in a particularly good way either. … READ MORE …
Filed under: Diagnosis, Risk, Uncategorized | Tagged: PSA, screening, testing, USPSTF | 6 Comments »
A newly published article in the journal Cancer suggests that, in fact, the USPSTF guidance on use of the PSA test for risk of prostate cancer has had little impact in the “real world” between 2010 and 2015 (at least at one large tertiary care institution in Texas). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: frequency, PSA, screening, test, USPSTF | Leave a comment »
PCPC3 — the patient-centered prostate cancer collaborative coalition — has just issued a statement about the revised research plan issued by the U.S. Preventive Services Task Force (USPSTF) in reassessing the value of PSA screening for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: preventive, PSA, screening, services, testing, USPSTF | 1 Comment »
Yesterday the U.S. Preventive Services Task Force (USPSTF) posted detailed information about a new draft research plan related to screening for prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: benefit, PSA, research, risk, screening, testing, USPSTF | 6 Comments »
Dr. Gerald Chodak has raised an interesting reason why physicians may want to think hard about the U.S. Preventive Services Task Force’s recommendation on the value of PSA testing for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, PSA, risk, test, USPSTF | 8 Comments »
A study just published in the American Journal of Preventive Medicine suggests that “The new USPSTF recommendation against PSA testing in all men may be met with resistance” on the part of male consumers. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: PSA test, screening, USPSTF | 4 Comments »
